FI954404A0 - Fenoksifenyylietikkahappojohdannaiset - Google Patents
FenoksifenyylietikkahappojohdannaisetInfo
- Publication number
- FI954404A0 FI954404A0 FI954404A FI954404A FI954404A0 FI 954404 A0 FI954404 A0 FI 954404A0 FI 954404 A FI954404 A FI 954404A FI 954404 A FI954404 A FI 954404A FI 954404 A0 FI954404 A0 FI 954404A0
- Authority
- FI
- Finland
- Prior art keywords
- vasospasm
- cerebral
- asthma
- hypertension
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3445593A | 1993-03-19 | 1993-03-19 | |
US19746794A | 1994-02-24 | 1994-02-24 | |
PCT/US1994/002871 WO1994021590A1 (fr) | 1993-03-19 | 1994-03-17 | Derives d'acide phenoxyphenylacetique |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954404A FI954404A (fi) | 1995-09-18 |
FI954404A0 true FI954404A0 (fi) | 1995-09-18 |
Family
ID=26710968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954404A FI954404A0 (fi) | 1993-03-19 | 1995-09-18 | Fenoksifenyylietikkahappojohdannaiset |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0617001B1 (fr) |
JP (1) | JPH08508034A (fr) |
KR (1) | KR960700992A (fr) |
CN (1) | CN1119434A (fr) |
AT (1) | ATE189217T1 (fr) |
AU (1) | AU679710B2 (fr) |
CA (1) | CA2119051A1 (fr) |
CZ (1) | CZ233595A3 (fr) |
DE (1) | DE69422742T2 (fr) |
DK (1) | DK0617001T3 (fr) |
ES (1) | ES2141197T3 (fr) |
FI (1) | FI954404A0 (fr) |
GR (1) | GR3032643T3 (fr) |
HR (1) | HRP940179B1 (fr) |
HU (1) | HU217028B (fr) |
IL (1) | IL108944A0 (fr) |
NO (1) | NO953672L (fr) |
NZ (1) | NZ263414A (fr) |
PL (1) | PL175786B1 (fr) |
PT (1) | PT617001E (fr) |
RU (1) | RU2139273C1 (fr) |
SK (1) | SK114795A3 (fr) |
WO (1) | WO1994021590A1 (fr) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) * | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
CA2195758A1 (fr) * | 1994-08-08 | 1996-02-22 | Scott W. Bagley | Derives de l'acide phenoxyphenylacetique |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
US5559135A (en) * | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
CA2211646C (fr) * | 1995-01-27 | 2008-09-09 | Rhone Poulenc Rorer Limited | Composes phenyles substitues utilises comme antagonistes de l'endotheline |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
DE19527568A1 (de) | 1995-07-28 | 1997-01-30 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19530032A1 (de) * | 1995-08-16 | 1997-02-20 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19537548A1 (de) * | 1995-10-09 | 1997-04-10 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
JPH09124620A (ja) * | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
EP0873334A1 (fr) * | 1995-12-12 | 1998-10-28 | Merck & Co., Inc. (a New Jersey corp.) | Procede relatif a la fabrication d'un antagoniste de l'endotheline |
US5688974A (en) * | 1995-12-12 | 1997-11-18 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5977117A (en) * | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
WO1997027847A1 (fr) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Methode de traitement du diabete et d'etats pathologiques associes |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
NZ330464A (en) | 1996-02-20 | 2000-04-28 | Bristol Myers Squibb Co | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
DE19653024A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
AU6187898A (en) * | 1997-01-30 | 1998-08-25 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
DE19710831A1 (de) * | 1997-03-15 | 1998-09-17 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
AU750755B2 (en) | 1997-09-26 | 2002-07-25 | Abbvie Deutschland Gmbh & Co Kg | Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
GB9722287D0 (en) * | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
DE19747788A1 (de) | 1997-10-29 | 1999-05-06 | Basf Ag | Substituierte 2-(2'-Pyridyloxy)phenylessigsäureamide, ihre Herstellung und Verwendung, sowie sie enthaltende Mittel |
AU3011299A (en) * | 1998-03-23 | 1999-10-18 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
ID26096A (id) * | 1998-03-31 | 2000-11-23 | Tanabe Seiyaku Co | Zat untuk pencegahan atau pengobatan disuria |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
AU3718900A (en) | 1999-03-19 | 2000-10-09 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
WO2001027077A2 (fr) * | 1999-10-12 | 2001-04-19 | Basf Aktiengesellschaft | Procede d'identification d'inhibiteurs de cdc25 |
AU2002217999A1 (en) | 2000-11-01 | 2002-05-15 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
US7091230B2 (en) | 2001-02-09 | 2006-08-15 | Merck & Co., Inc. | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
ZA200407802B (en) * | 2002-03-20 | 2006-11-29 | Metabolex Inc | Substituted phenylacetic acids |
US8614236B2 (en) | 2006-12-12 | 2013-12-24 | University Of Washington | Methods of treating pulmonary disease using acetazolamide and structurally related derivatives |
CN101042381B (zh) * | 2007-04-28 | 2014-01-08 | 长春迈灵生物工程有限公司 | 一种地舍平的检测方法 |
AU2010315946A1 (en) * | 2009-11-09 | 2012-05-31 | Medivir Ab | Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
EP2590951B1 (fr) | 2010-07-09 | 2015-01-07 | Pfizer Limited | Benzènesulfonamides utiles en tant qu'inhibiteurs des canaux sodiques |
WO2012007877A2 (fr) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Composés chimiques |
US9096500B2 (en) | 2010-07-12 | 2015-08-04 | Pfizer Limited | Acyl sulfonamide compounds |
ES2525581T3 (es) | 2010-07-12 | 2014-12-26 | Pfizer Limited | Derivados de N-sulfonilbenzamida útiles como inhibidores del canal de sodio dependiente de voltaje |
WO2012007883A1 (fr) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Composés chimiques |
WO2012007869A2 (fr) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Composés chimiques |
MX2013006768A (es) | 2010-12-23 | 2013-07-22 | Pfizer | Moduladores de receptor de glucagon. |
EA023517B1 (ru) | 2011-02-08 | 2016-06-30 | Пфайзер Инк. | Модуляторы глюкагонового рецептора |
US8927577B2 (en) | 2011-07-22 | 2015-01-06 | Pfizer Inc. | Quinolinyl glucagon receptor modulators |
CA2857603C (fr) | 2011-12-15 | 2016-08-02 | Pfizer Limited | Derives de sulfonamide |
CN111825564B (zh) * | 2020-09-21 | 2020-12-29 | 西藏甘露藏药股份有限公司 | 一种从渣驯中提取的化合物、制备方法及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1408738A (fr) * | 1964-04-29 | 1965-08-20 | Nobel Bozel | Nouveaux dérivés de l'acide bis(hydroxy-4-phényl)-acétique |
US4748272A (en) * | 1986-08-01 | 1988-05-31 | Rorer Pharmaceutical Corp. | Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways |
JPS63122605A (ja) * | 1986-11-10 | 1988-05-26 | Tokuyama Soda Co Ltd | 除草剤組成物 |
-
1994
- 1994-03-10 AT AT94301728T patent/ATE189217T1/de not_active IP Right Cessation
- 1994-03-10 PT PT94301728T patent/PT617001E/pt unknown
- 1994-03-10 DK DK94301728T patent/DK0617001T3/da active
- 1994-03-10 DE DE69422742T patent/DE69422742T2/de not_active Expired - Fee Related
- 1994-03-10 ES ES94301728T patent/ES2141197T3/es not_active Expired - Lifetime
- 1994-03-10 EP EP94301728A patent/EP0617001B1/fr not_active Expired - Lifetime
- 1994-03-11 IL IL10894494A patent/IL108944A0/xx unknown
- 1994-03-15 CA CA002119051A patent/CA2119051A1/fr not_active Abandoned
- 1994-03-17 SK SK1147-95A patent/SK114795A3/sk unknown
- 1994-03-17 WO PCT/US1994/002871 patent/WO1994021590A1/fr not_active Application Discontinuation
- 1994-03-17 JP JP6521226A patent/JPH08508034A/ja not_active Withdrawn
- 1994-03-17 CZ CZ952335A patent/CZ233595A3/cs unknown
- 1994-03-17 NZ NZ263414A patent/NZ263414A/en unknown
- 1994-03-17 CN CN94191512A patent/CN1119434A/zh active Pending
- 1994-03-17 PL PL94310661A patent/PL175786B1/pl unknown
- 1994-03-17 HU HU9502725A patent/HU217028B/hu not_active IP Right Cessation
- 1994-03-17 RU RU95121625A patent/RU2139273C1/ru active
- 1994-03-18 HR HR940179A patent/HRP940179B1/xx not_active IP Right Cessation
- 1994-03-18 AU AU57878/94A patent/AU679710B2/en not_active Ceased
-
1995
- 1995-09-18 FI FI954404A patent/FI954404A0/fi unknown
- 1995-09-18 KR KR1019950704018A patent/KR960700992A/ko not_active Application Discontinuation
- 1995-09-18 NO NO953672A patent/NO953672L/no not_active Application Discontinuation
-
2000
- 2000-02-11 GR GR20000400340T patent/GR3032643T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1119434A (zh) | 1996-03-27 |
ATE189217T1 (de) | 2000-02-15 |
NO953672D0 (no) | 1995-09-18 |
KR960700992A (ko) | 1996-02-24 |
NO953672L (no) | 1995-11-17 |
PL310661A1 (en) | 1995-12-27 |
AU679710B2 (en) | 1997-07-10 |
HU217028B (hu) | 1999-11-29 |
HUT73658A (en) | 1996-09-30 |
EP0617001A1 (fr) | 1994-09-28 |
JPH08508034A (ja) | 1996-08-27 |
HRP940179B1 (en) | 2000-10-31 |
CZ233595A3 (en) | 1996-01-17 |
ES2141197T3 (es) | 2000-03-16 |
GR3032643T3 (en) | 2000-06-30 |
CA2119051A1 (fr) | 1994-09-20 |
FI954404A (fi) | 1995-09-18 |
PL175786B1 (pl) | 1999-02-26 |
DE69422742T2 (de) | 2000-08-17 |
HRP940179A2 (en) | 1998-02-28 |
WO1994021590A1 (fr) | 1994-09-29 |
DK0617001T3 (da) | 2000-04-17 |
NZ263414A (en) | 1997-09-22 |
HU9502725D0 (en) | 1995-11-28 |
DE69422742D1 (de) | 2000-03-02 |
SK114795A3 (en) | 1996-06-05 |
PT617001E (pt) | 2000-06-30 |
IL108944A0 (en) | 1994-06-24 |
AU5787894A (en) | 1994-09-22 |
RU2139273C1 (ru) | 1999-10-10 |
EP0617001B1 (fr) | 2000-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI954404A0 (fi) | Fenoksifenyylietikkahappojohdannaiset | |
MX9308191A (es) | Antagonistas de endotelina. | |
NO986090L (no) | Fenylalaninderivater som integrininhibitorer | |
EA199800478A1 (ru) | N-([1,2,4]триазолазинил)бензолсульфонамиды и пиридинсульфонамиды и их применение в качестве гербицидов | |
DE69435198D1 (de) | "hedgehog-like" proteine von wirbeltieren, die embryonale strukturen induzieren | |
CA2297911A1 (fr) | 6-phenylphenanthridines substitues | |
ATE323088T1 (de) | Bicyclische pyridin-und pyrimidinderivate als neuropeptid y rezeptorantagonisten | |
AP9701004A0 (en) | Low molecular weight bicyclic thrombin inhibitors. | |
IS5258A (is) | Pýrazín afleiður og notkun þeirra sem bólgueyðandi miðlar | |
DE69908648D1 (de) | Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung | |
CA2382406A1 (fr) | Composes de 2-arylbenzazole substitues et leur utilisation comme agents antitumoraux | |
HK1003031A1 (en) | Condensed pyrimidine derivatives and their use as angiotensine ii antagonists | |
DE59409833D1 (de) | Piperazinderivate | |
PT1023267E (pt) | Compostos de piridilo e composicoes farmaceuticas que os contem | |
WO2000071516A3 (fr) | INHIBITEURS DU FACTEUR Xa | |
ATE292633T1 (de) | Substituierte piperazinderivate und ihre verwendung als fettsaüreoxidationsinhibitoren | |
PT811001E (pt) | Dioxidos de benzotiazina como antagonistas de endotelina | |
DK0980374T3 (da) | Phosphodiesterase 4-inhiberende diazepinoindoloner. | |
MX9202191A (es) | Antagonistas de endotelina. | |
ES2186734T3 (es) | Quinazolinas como inhibidores de la enzima de conversion de la endotelina. | |
PL326236A1 (en) | Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them | |
DK478585D0 (da) | 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse | |
AR012094A1 (es) | Derivados de quinolein-2(1h)-ona y de dihidroquinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica. | |
ATE86983T1 (de) | Acyl-derivate von hydroxy-pyrimidinen. | |
MX12192A (es) | Composicion farmaceutica para reducir o impedir las arritmias |